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Abstract
As the so-called “Mothership of the Human Genome,” the cell nucleus must keep
all vital genetic information safe, but accessible, inside a strong protective envelope. The
inner membrane of the nuclear envelope is lined by tough but adaptable proteins called
lamins. While lamins polymerize into fibrous structures that hold up the “walls” of the
nucleus, they also serve as an internal scaffold for the complex machinery involved in
DNA replication and gene expression. It is in this later role that we have been looking for
clues to premature and possibly to normal aging. One type of lamins, Lamin A is made
through an unusual pathway involving a lipid dependent cleavage of a larger precursor
called prelamin A1-3. The functional significance of this processing pathway is that
prelamin A cannot assemble and is inhibitory of proper lamina formation. Pathological
cases of immature lamin A accumulation include Hutchinson-Gilford progeria syndrome
(HGPS) or Progeria characterized by premature aging and Restrictive Dermopathy (RD),
a lethal prenatal disease. We have previously shown that accumulation of prelamin A
leads to cell cycle arrest and drastic changes in expression of genes involved in cell cycle
control, among those, several members of the FoxO family of transcription factors.
The goal of this study was to determine the mechanisms by which accumulation
of uncleavable prelamin A activates FoxO-mediated cell cycle arrest. Cells expressing an
uncleavable form of Lamin A in an inducible manner were used to determine subcellular
distribution of FoxO3a upon accumulation of prelamin A. This was done by indirect
immunofluorescence and Western blotting. The proliferation rate of these cells and
controls expressing wild type Lamin A was also determined by measuring the
incorporation of BrdU into DNA.
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During these experiments, it was hypothesized and observed that overexpression
of prelamin A leads to redistribution of FoxO3a from the cytoplasm of the cell to the
nucleoplasm. Expression of FoxO3a target genes was accordingly increased, leading to a
decrease in cell proliferation.
The information obtained from this study could not only be of interest in
broadening our knowledge of the mechanisms of quiescence and aging in general, but
also could inform the discussion of the use of several therapeutics for the treatment of
Progeria and other diseases that result from the accumulation of prelamin A.
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Chapter 1. INTRODUCTION
The genetic diseases Hutchinson-Gilford Progeria Syndrome (HGPS) and
Restrictive Dermopathy (RD) both arise from defects in the endoproteolytic processing
pathway of prelamin A. The formation of lamin A, from its precursor prelamin A, is an
unusual protein maturation pathway in that it requires two farnesylation-dependent
endoproteolytic cleavages. The second cleavage in this pathway is unique to lamin A in
higher vertebrates and carried out by the protease zmpste24.
While Restrictive Dermopathy is lethal, patients with HGPS live, but exhibit
premature aging which leads to a life expectancy of ~13 years. In RD, the defect is a loss
of function of zmpste24. In HGPS, there is a mutation in the prelamin A gene that deletes
the second site where zmpste24 cuts prelamin A. Thus, in both diseases, immature
prelamin A accumulates, inducing cell quiescence and senescence among other dramatic
changes in the nuclear structure and function. In cell culture models, induction of cell
quiescence is co-related with both zmpste24 down-regulation and prelamin A
accumulation1.
In both diseases, similar forms of prelamin A accumulate. Remarkably, it has
been shown that the form of farnesylated and carboxymethylated prelamin A that arises
in HGPS, known as progerin or Lamin A !50, also occurs at low levels in normal human
cells and that its expression produces aging-associated phenotypes. The current literature
on prelamin A indicates a role for its accumulation in cellular senescence, as well as,
quiescence.
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The Forkhead box O (FoxO) transcription factors are emerging as an important
family of proteins that modulate the expression of genes involved in apoptosis, the cell
cycle, and other cellular functions 4. Four isoforms of the FoxO transcription factors are
found in mammals- FoxO1, FoxO3, FoxO4, and FoxO6. Akt-dependent phosphorylation
critically regulates three of the four FoxO isoforms- FoxO1, FoxO3, and FoxO4.
Furthermore, it has been shown that, in normal cells, Akt-dependent phosphorylation of
FoxO factors promotes FoxO export from the nucleus to the cytoplasm, thereby
repressing FoxO transcriptional function.
This family of transcription factors
is characterized by a conserved DNAbinding domain (the ‘Forkhead box’ or
FOX). They participate in diverse
processes from apoptosis to cell-cycle
progression to oxidative stress resistance.
As shown in Figure 1, FoxO factors can

Figure 1. FoxO transcription factors. Adapted from Carter Me
and Brunet A. (2007) Current Biology 7(4):R113-114.

promote cell cycle arrest by upregulating
the cell-cycle inhibitor p27Kip1 to induce
G1 arrest or GADD45 to induce G2 arrest 5. FoxO proteins are negatively regulated by
the P13K/Akt signaling pathway. Phosphorylation at three conserved residues by Akt
results in the export of FoxO factors from the nucleus to the cytoplasm, thereby inhibiting
FoxO dependent transcription. FoxO proteins are also negatively regulated by a peptidylprolyl isomerase called pin1 6. This enzyme also prevents the nuclear accumulation of
FoxO proteins.
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In a study of FoxO transcription factors in the maintenance of cellular
homeostasis during aging, Salih and Brunet have shown that the FoxO factors coordinate
glucose homeostasis, angiogenesis, stem cell maintenance, immune, muscular, and
neuronal functions, with implications for diabetes, cancer, autoimmune diseases and
neurodegeneration 7. FoxO factors have been shown to regulate other cellular responses
in addition to those listed above. Elucidating how FoxO factors operate at the molecular
level will provide important insights into their organismal function. For this reason, the
focus of this study will lie in exploring the involvement of FoxO proteins in the
regulation of cell cycle arrest induced by accumulation of prelamin A. It is hypothesized
that when uncleavable prelamin A is expressed in 3T3 cells, FoxO proteins will migrate
to the nucleus and induce cell cycle arrest through the upregulation of the p27Kip1 cyclindependent kinase inhibitor.
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Chapter 2. METHODS AND MATERIALS

Creation of uncleavable prelamin A expressing L647R cell line
In normal cells, Lamin A protein is processed by the post-translational pathway
described in Figure 2.

Figure 2. Maturation of Lamin A Protein by Proteolytic Post-Translational
Processing. The precursor protein undergoes successive modifications: by the
enzyme FT (which attaches a farnesyl moiety), followed by Zmpste24- or Rce1mediated cleavage of the – SIM residues (AAXing), after which ICMT methylates
the carboxyl terminus, signalling the 2nd proteolysis, by Zmpste24 (uniquely)
between the tyrosine (Y) and leucine (L) residues of the RSYLLG Zmpste24
recognition site, releasing the 2kDa farnesylated c-terminal fragment to yield
mature LA (72 kDa).
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In order to develop cells which expressed an uncleavable prelamin A protein, sitedirected mutagenesis was used to mutate the Zmpste24 cleavage site in the Lamin A
cDNA sequence in a green fluorescent protein-tagged recombinant vector-based
expression system, thus generating a full-length Prelamin A protein that was unable to
undergo the final maturation cleavage to form mature Lamin A. The construct, pEGFPC3-EGFP-LMNA-L647R, produces an EGFP-tagged protein termed “L647R Prelamin
A,” in which the CaaX-box is intact, so the farnesyl modification, -aaX cleavage, and
carboxyl methylation can occur as for Wild-Type Prelamin A8.

Measuring BrdU incorporation into DNA
3T3 cells and L647R rheoswitch cells9 (expressing an uncleavable prelamin AGFP chimera) were seeded in triplicate at 4 x 103 cells/well in a 96-well plate and
incubated overnight. Cells were then treated with 0nM, 200nM, 400nM, 600nM, and
800nM concentrations of GenoStat inducer, or DMSO, as a control, for 48 hours. 10 µM
BrdU was then added to each well in the plate and cells were incubated for 4 hours. BrdU
incorporated into DNA was detected by incubation with monoclonal anti-BrdU antibody
linked to HRP. The HRP substrate TMB was used to develop the color. After 30 minutes
of development, stop solution was added and absorbance at 450 nm was measured using
a platereader. The quantification of absorbance represented the amount of BrdU
incorporated into the cells, and indicated the level of proliferation occurring in the
corresponding cells.
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Indirect Immunofluorescence
Indirect Immunofluorescence was used to examine intracellular protein
localization. Before visualizing the proteins, growth medium was removed, the cells were
washed with 1x PBS and pure DMEM medium was added to the cells for visualization.
The cells were harvested by trypsinization before being transferred to coverslip chamber
dishes and plated on glass coverslips, which were incubated overnight in regular growth
medium. Cells received treatment and were then incubated for 48 hours. After incubation,
the cells were rinsed with 1x PBS prior to fixing by incubation with 4% formaldehyde
PBS for 15 minutes at room temperature. The cells underwent three PBS washes, and
were then permeabilized with 0.2% Triton X-100 in PBS for five minutes on ice, washed,
and blocked with 10% BSA in PBS for five minutes on ice. The cells were incubated
with primary antibody for one hour at room temperature, washed and incubated with a
secondary, fluorophore conjugated, antibody for one hour. Following the second
incubation, cells were washed three times with PBS then treated with DAPI-containing
anti-fade Mounting Medium to seal the stained cells between the coverslip and a
microscope slide. Images were obtained using a Nikon Diaphot200 microscope with a
Oimaging Retiga 2000 cooled CCD digital camera.

Determining the cellular location of FoxO3a protein in prelamin A induced and
uninduced 3T3 cells
Prelamin A expressing L647R Rheoswitch 3T3 cells and control 3T3 cells were
plated on coverslips and incubated overnight in regular growth medium. Experimental
cells were incubated for 48 hours in the presence of Genostat inducer (500 mM). Un-
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induced control cells of both types were incubated for 48 hours in the presence of DMSO.
Cells were then fixed in 4% formaldehyde and analyze by indirect immunofluorescence
with antibodies against FoxO3 over GFP. Secondary antibodies were Alexa 565 and 488
respectively.

Separation of Proteins by Electrophoresis
All samples were solubilized by the addition of 1XNuPAGE LDS Buffer and 10%
Bond Breaker (reducing agent) as well as heated in a sand bath for 5 minutes. The
samples were then cooled back to room temperature before loading an aliquot of each
sample onto a pre-cast one-dimensional denaturing NuPAGE Noxvex 4-12% Bis-Tris
SDS PAGE gel. A constant 200 volts for approximately 1-1.5 hour were used to perform
the electrophoresis. Protein standards were also run with the samples to enable the
estimation of apparent molecular weights for each sample.

Protein Blotting and Immunodetection
The protein gel transfer to a nitro-cellulose membrane was accomplished using
the iBlot, a dry electroblotter. Manufacturer protocol was followed (Invitrogen/Life
Technologies, USA). The transfer process lasted approximately 7 minutes. After transfer,
the membranes were examined to verify protein transfer as evidenced by the visibility of
standard bands. If transfer was confirmed, the membrane was then blocked in 1X TBST /
5% Nonfat milk for 1 hour at room temperature or overnight at 4ºC. Following blocking,
the membrane was washed for 10min, 3 x 5min, and 10min, respectively, in 1X TBST
and then incubated with primary antibody diluted to the manufacturer suggested
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concentration in 1X TBST / 5% Nonfat milk for 1 hour at room temperature or overnight
at 4ºC. The washings were repeated after primary incubation. The membrane was then
incubated with a 1X TBST / 5% Nonfat milk diluted secondary antibody-HRP conjugate
at room temperature for one hour. Washings were repeated to remove excess secondary
antibody conjugate. Bathing the membrane in an ECL chemiluminescence reagent bath
for 5minutes at room temperature, then draining the excess reagent and wrapping the
membrane in a plastic film allowed protein band detection. The film was imaged using a
Chemiluminescence Imaging System with digital photo documentation capability.

Measuring changes in FoxO3a subcellular distribution in response to L647R
prelamin A expression and Juglone
L647R Rheoswitch 3T3 cells (2x106) were plated on 10 cm plates and incubated
for 48 hours in the presence of GenoStat inducer (500 mM) or DMSO plus the addition of
0, 5, or 15 mM of Juglone, an inhibitor of pin1. Cells were washed with PBS and scraped
in 1ML PBS plus 0.1 % NP40. Cells were pipetted up and down five times to break up
the cells and then 300 "L were taken from each tube and labeled as whole cell lysate
(W). The remaining 700 "L were centrifuged in an Eppendorf centrifuge for 10 seconds
at maximum speed. The supernatant was separated from the precipitate and an aliquot of
300 "L was taken (cytoplasm, C). The pellet was resuspended in PBS plus NP40 and
centrifuged again for 10 seconds at maximum speed. The pellet was resuspended in
300"L of 1x PBS/NP40 (Nuclear, N). Aliquots containing DNA (W and N) were
sonicated for 5 seconds to break up the DNA. Samples were analyzed by Western
blotting and G-box image analysis.
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Measuring changes in expression and subcellular distribution of p27kip in response
to L647R prelamin A expression and Juglone
Experimental methods followed those of the above test, which measured changes
in FoxO3a subcellular distribution in response to L647R prelamin A expression and
Juglone.
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Chapter 3. RESULTS

Prelamin A induced cell cycle arrest
The measurement of BrdU incorporation into cellular DNA was used to
demonstrate the effects of prelamin A accumulation on cell cycle progression. In
previous experiments we have shown that prelamin A accumulation is a cause, rather
than a by product, of cell cycle arrest, and that, L647R prelamin A expressing cells
exhibit decreased proliferation 8.
To monitor cellular proliferation in control, 3T3 cells, and experimental, prelamin
A expressing L647R cells, a bromodeoxyuridine (BrdU) uptake assay was performed.
This assay was used to monitor cellular proliferation by labeling only newly synthesized
DNA with BrdU. BrdU incorporation was measured by first treating the cells with an
anti-BrdU antibody linked to HRP, and then measuring the absorbance of each cell group
at 450nm to detect the presence of HRP (Figure 3). Control 3T3 cells that do not contain
a lamin expression vector, and cells from the L647R prelamin A expressing cell line,
were treated with various concentrations of GenoStat, an inducer, or DMSO, a control,
for 48 hours before the addition of BrdU to the medium to label actively proliferating
cells. Examination of Figure 3 reveals that BrdU incorporation and, thus, cell
proliferation, drastically decreases with the GenoStat induction of prelamin A
accumulation in the induced L647R cells. The possible concern that repression of
proliferation in the L647R cells may result from the toxicity of increasing GenoStat
dosage, is dismissed by the lack of inhibition of proliferation in the unmodified 3T3 cells
which were also treated with GenoStat inducer. In addition, the lack of proliferation
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inhibition seen in L647R cells treated with DMSO, provides evidence that the activation
of prelamin A expression in GenoStat induced L647R cells results in a decrease in
proliferation of these cells.

Figure 3. BrdU Incorporation into DNA. 3T3 cells (Squares) or L647R
rheoswitch cells (Triangles) were seeded in triplicate at 4 x 103 cells/well in a 96well plate and incubated overnight. Cells were then treated with various
concentrations of GenoStat inducer (filled symbols) or DMSO (empty symbols)
for 48 hours. Finally, 10 µM BrdU was added to the plate and cells were
incubated for 4 hours. BrdU incorporated into DNA was detected by incubation
with monoclonal anti-BrdU antibody linked to HRP. The HRP substrate TMB
was used to develop the color and measure absorbance at 450 nm.
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FoxO3a subcellular re-distribution upon prelamin A accumulation
After showing that the accumulation of prelamin A induces cell cycle arrest, the
second experiment was designed to investigate the impact of prelamin A accumulation on
FoxO3a proteins within the cells. In this experiment, immunofluorescence imaging was
used to determine if FoxO3a proteins were localized to the nucleus in L647R prelamin A
expressing cells, as compared to uninduced control cells (Figure 4- top panel). Cells were
treated with anti-FoxO3a antibody to reveal the diffuse expression of FoxO3a throughout
the uninduced cells, and the significant increase in nuclear-concentrated FoxO3a
expression in prelamin A induced cells.
Furthermore, treatment of the cells with an anti-GFP antibody (Figure 4-middle
panel) revealed accumulation of GFP-tagged L647R prelamin A nucleoplasm and nuclear
rim of the induced cells. This prelamin A induced florescence is absent from uninduced
cells.
When the two immunoflorescent images are overlaid (Figure 4- bottom panel),
the nuclear colocalization of FoxO3a and prelaminA becomes clear; however, neither
nuclear localization nor prelamin A accumulation are present in the uninduced image
overlay.
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Figure 4. FoxO3a sub cellular re-distribution upon prelamin A accumulation in
3T3 cells. L647R Rheoswitch 3T3 cells were plated on coverslips and incubated
overnight in regular growth medium. Cells were then incubated for 48 hours in
the presence of GenoStat inducer (500 mM) or DMSO. Cells were then fixed in
4% formaldehyde and analyzed by indirect immunofluorescence with antibodies
against FoxO3 over GFP. Secondary antibodies were Alexa 565 and 488
respectively.
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Changes in FoxO3a subcellular distribution in response to Juglone
The experiment “FoxO3a subcellular re-distribution upon prelamin A
accumulation” in this study showed that L647R prelamin A expression increases
expression of FoxO3a and the nuclear translocation of the protein. Because nuclear
localization of FoxO3a is correlated with activation of the protein, these findings also
indicate a higher level of FoxO3a activation in prelamin A induced cells. Furthermore, it
was shown through additional experiments accompanying this study that, p27Kip1, a FoxO
target for transcriptional activation, is also translocated to the cell nucleus, and, its
expression increased upon prelamin A accumulation and FoxO3 nuclear translocation.
This finding offers support for a prelamin A-induced effect on FoxO activation, and
suggests a viable potential mechanism for prelamin A-mediated cell cycle arrest 8.
Given that pin1 is known to suppress FoxO proteins function, it is expected that
the increased presence of pin1 in the nucleus of prelamin A induced cells would result in
decreased FoxO activity. However, when the pathway is examined as a whole, data
suggests that pin1-mediated suppression of FoxO nuclear translocation is inhibited in
prelamin A induced cells 8. In order to test this hypothesis, the effects of treatment with
Juglone, a pin1 inhibitor, on FoxO nuclear translocation were observed (Figures 4 and 5).
This experiment was also used to biochemically confirm the translocation of FoxO3a to
the nucleus of cells expressing uncleavable prelamin A. This was accomplished by
performing a nuclear-cytoplasmic fractionation on the whole cell lysate of both control
3T3 cells and L647R cells expressing prelamin A. Nuclear, cytoplasmic, and whole cell
samples of each cell type were electrophoresed using a 4-12% gradient SDS-PAGE gel.
These gels were interpreted with western blotting techniques, knowing that the molecular
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weight of FoxO3a is approximately 80Kd. The results of this experiment show that
inhibition of pin1 by Juglone leads to the nuclear redistribution of FoxO3a in control,
uninduced cells, and, that cells expressing uncleavable prelamin A show higher total
levels of FoxO3a in the nuclear fractions at all concentrations of pin1 inhibitor
administered.

Figure 5. Western Blot Evidence for Changes in FoxO3a subcellular distribution
in response to L647R prelamin A expression and pin1 inhibitor Juglone. L647R
Rheoswitch 3T3 cells (2x106 were plated on 10 cm plates and incubated for 48
hours in the presence of GenoStat inducer (500 mM) or DMSO plus the addition
of 0, 5, or 15 mM of Juglone, an inhibitor of pin1. Cells were washed with 1x
PBS and scraped in 1ML 1x PBS plus 0.1 % NP40. Cells were pipetted up and
down five times to break up the cells and then 300 "L were taken from each tube
and labeled as whole cell lysate (W). The remaining 700 "L were centrifuged in
an Eppendorf centrifuge for 10 seconds at maximum speed. The supernatant was
separated from the precipitate and an aliquot of 300 "L was taken (cytoplasm, C).
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The pellet was re-suspended in 1x PBS plus NP40 and centrifuged again for 10
seconds at maximum speed. The pellet was resuspended in 300 "L of 1x PBS/
NP40 (Nuclear, N). Aliquots containing DNA (W and N) were sonicated for 5
seconds to break up the DNA. Samples were analyzed by Western blotting.

Figure 6. Graphical Analysis of Western Blot Evidence for Changes in FoxO3a
subcellular distribution in response to L647R prelamin A expression and pin1
inhibitor Juglone. This bar graph shows a quantitation of the bands shown in
Figure 5 using a G-Box image analysis instrument.
Changes in p27Kip subcellular distribution in response to Juglone
In conjunction with the previous experiment, the effects of treatment with Juglone
and prelamin A accumulation on p27Kip expression and localization were also observed.
P27Kip1 is a FoxO3a regulated molecule. The same membrane used in the previous
experiment was stripped and reprobed. However, instead of probing for FoxO3a, the
focus was p27Kip, which has a molecular weight of 27Kd. From this experiment, it can be
seen that p27Kip is elevated in the induced uncleavable prelamin A cells as compared to
the controls, and that the majority of the protein is localized in the nucleus. In addition,
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the degree of p27Kip elevation increases as the Juglone treatment dosage is increased in
both the control and induced cells. It is also important to note that the induced cells have
higher initial levels of p27Kip, and that expression in these cells as compared to the
uninduced cells without Juglone treatment, exhibits little significant change induced by
pin1 inhibition.

Figure 7. Western Blot Evidence for Changes in expression and subcellular
distribution of p27Kip1 (FoxO proteins regulated molecule) in response to L647R
expression and pin1 inhibitor, Juglone. The membrane used in Figure 5 was
stripped and reprobed using an anti-p27Kip antibody.
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Figure 8. Graphical Analysis of Western Blot Evidence for Changes in expression
and subcellular distribution of p27Kip1 (FoxO proteins regulated molecule) in
response to L647R expression and pin1 inhibitor Juglone. This bar graph shows a
quantitation of the bands shown in Figure 7 using a G-Box image analysis
instrument.
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Chapter 4. DISCUSSION AND CONCLUSION
Over the course of this study, techniques such as immunoflouresence and western
blotting have been used to further study the mechanisms by which prelamin A activates
FoxO-mediated cell cycle arrest. The mechanisms involved in this process were found to
include: translocation of FoxO3a to the nucleus in the presence of uncleavable prelamin
A, inhibition of pin1, and upregulation of p27Kip. It was hypothesized and observed that
when uncleavable prelamin A is expressed in 3T3 cells, FoxO proteins migrate to the cell
nucleus and induce cell cycle arrest through the upregulation of the p27 cyclin-dependent
kinase inhibitor.
The first experiments of this study utilized BrdU incorporation into DNA to
demonstrate how prelamin A accumulation induces cell cycle arrest, and indirect
immunoflouresence to reveal the effects of this accumulation on sub cellular
redistribution of FoxO3a. From the first experiment, it can be concluded that prelamin A
accumulation is a cause, rather than an effect, of cell cycle arrest. In addition, the
protein’s accumulation during the cell cycle itself, as evidenced by prelamin A
accumulation due to a lack of maturation processing, is a possible mechanism for
proliferating cells to coordinate their exit from the cell cycle. The results of this
experiment supported existing data concerning the role of prelamin A accumulation in the
cell cycle, and prompted further exploration of this process with regards to the role of
FoxO3a. The indirect immunoflouresence of both control and prelamin A induced cells
shown in Figure 4 was used to provide visual evidence for the nuclear accumulation of
prelamin A, as well as, the nuclear translocation of FoxO3a proteins in prelamin A
expressing cells.
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In studies by graduate student, Christina Bridges, Ph. D., it was shown that
activity of the Akt phosphorylating pathway is downregulated when prelamin A is
expressed8. Because Akt is the major inducing kinase of FoxO phosphorylationdependent export from the nucleus, the observed downregulation of Akt is consistent
with the nuclear localization and activated FoxO transcriptional regulation noted in this
study. Additionally, pin1 has been shown to be a primary mediator of the Akt pathway,
and inhibition of pin1 results in the destabilization and degradation of Akt. It is proposed
that prelamin A binds and sequesters pin1, such that pin1 inhibition, and thus Akt
downregulation can be mimicked by prelamin A accumulation. Therefore, if pin1 is
inhibited by either Juglone or prelamin A accumulation, FoxO should be localized to the
cell nucleus and actively transcribe target proteins such as p27Kip. These predictions are
supported by Figures 4, 5, 6 and 7, in which Juglone was used to inhibit pin1 in control
cells and prelamin A expressing cells. The results of both these studies support one
another and the relationship between FoxO3a nuclear translocation, pin1 and p27Kip
activity. Interestingly, while it was shown that treatment with pin1 inhibitor, Juglone,
increased nuclear translocation of FoxO3a and p27Kip in uninduced, control cells, the
prelamin A expressing, induced cells, which already exhibited an increased nuclear
translocation of FoxO3a and p27Kip proteins, did not show a significant increase. These
findings suggest that expression of prelamin A inhibits the negative effects of pin1 upon
FoxO3a nuclear translocation, and the resultant p27Kip expression, as well as, that
prelamin A acts through an undescribed mechanism to sequester pin1, limit its nuclear
availability and binding to targets. Christina Bridges, Ph. D. remarks that this mechanism
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of pin1 inhibition could have many consequences for cell cycle regulation due to the
many targets of pin1 activity 8.
In conclusion, these studies confirmed that expression of uncleavable prelamin A
induces cell cycle arrest, and revealed that: the presence of uncleavable prelamin A is
associated with the translocation of FoxO3a proteins to the nucleus; inhibition of pin1
leads to a redistribution of FoxO3a to the nucleus in uninduced cells; at all concentrations
of pin1 inhibitor, cells expressing uncleavable prelamin A show higher total levels and
increased amounts of FoxO3a in the nuclear fractions; inhibition of pin1 produces results
similar to those seen with the accumulation of prelamin A in that FoxO3a translocates to
the nucleus and upregulates p27Kip.
The goal of this study was to determine the mechanisms by which prelamin A
accumulation activates FoxO-mediated cell cycle arrest. The mechanisms involved in this
process were found to include: translocation of FoxO3a to the nucleus in the presence of
uncleavable prelamin A, inhibition of pin1, and upregulation of p27Kip. Further
experiments that can be done in order to gain a better understanding of these processes
include: determining the effects of pin1 overexpression, inhibition of pin1 by means other
than Juglone, exploration of the interactions between pin1 and prelamin A through site
directed mutations and development of more effective ways to quantitatively explore the
effects of pin1 and prelamin A accumulation in the translocation of FoxO3a to the cell
nucleus. Hopefully, when the overexpression of pin1 is studied, a reversal of the effects
of prelamin A accumulation will be seen, such that cell cycle arrest may be stopped. This
project and the further studies associated with it have several implications ranging from
improved treatment of rare disorders such as HGPS and RD, which involve abnormal
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aging phenotypes, to implications for the more common age-dependent pathologies such
as diabetes, cancer, autoimmune syndromes and neurodegeneration, and even the normal
aging process.
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